A cost--utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer.
about
Assessing outcomes in palliative chemotherapy.Pharmacoeconomic considerations in the treatment of breast cancer.Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective.Cost-utility analyses of drug therapies in breast cancer: a systematic review.Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer.Stakeholders in outcome measures: review from a clinical perspectiveThe Cost Effectiveness of Docetaxel and Active Symptom Control versus Active Symptom Control Alone for Refractory Oesophagogastric Adenocarcinoma: Economic Analysis of the COUGAR-02 Trial.Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancerEconomic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer.Economic evaluation of docetaxel for breast cancer
P2860
Q34660752-2A1DC6D8-4735-41BF-85A3-4D0BEF7F7116Q35205385-5C3BCC53-260B-49FA-8890-2B0303BA36F6Q35617654-F6BD9814-F270-4773-A018-94C97EB2E30EQ36116276-ECAD89C4-495D-45A4-900B-4328A810648CQ36249904-D02F8EBA-A09A-4F3B-9D88-E47C1EBA25B6Q37219624-11E4E22C-6D3B-4321-ADC3-A7AF7B780633Q38967142-907170EA-D358-4736-910F-3778B9BA205CQ39423484-7A783327-C949-4753-8401-A9E3BCF5B69BQ46226343-54EC7CE2-2078-4E63-B616-B72EF8A518A1Q57142650-9002FAB8-A0CB-4715-8463-4821BA41C3C4
P2860
A cost--utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A cost--utility analysis compa ...... with metastatic breast cancer.
@ast
A cost--utility analysis compa ...... with metastatic breast cancer.
@en
A cost--utility analysis compa ...... with metastatic breast cancer.
@nl
type
label
A cost--utility analysis compa ...... with metastatic breast cancer.
@ast
A cost--utility analysis compa ...... with metastatic breast cancer.
@en
A cost--utility analysis compa ...... with metastatic breast cancer.
@nl
prefLabel
A cost--utility analysis compa ...... with metastatic breast cancer.
@ast
A cost--utility analysis compa ...... with metastatic breast cancer.
@en
A cost--utility analysis compa ...... with metastatic breast cancer.
@nl
P2093
P1433
P1476
A cost--utility analysis compa ...... with metastatic breast cancer.
@en
P2093
Uyl-de Groot C
Willemse P
van Agthoven M
P304
P356
10.1097/00001813-200107000-00007
P577
2001-07-01T00:00:00Z